(Q36088805)

12 August 2017

Discontinuing hormone replacement therapy: attenuating the effect on CVD risk with lifestyle changes (English)

1 reference

Hormone Replacement Therapy

12 August 2017

1 reference

Andrea M Kriska

2

0 references

Trevor J. Orchard

object named as

Trevor J Orchard

5

0 references

Lewis Kuller

8

object named as

Lewis H Kuller

1 reference

12 August 2017

Kelley Pettee Gabriel

1

object named as

Kelley K Pettee

1 reference

12 August 2017

3

Molly B Conroy

1 reference

12 August 2017

B Delia Johnson

4

1 reference

12 August 2017

Bret H Goodpaster

6

1 reference

12 August 2017

Frani M Averbach

7

1 reference

12 August 2017

1 June 2007

1 reference

American Journal of Preventive Medicine

12 August 2017

1 reference

12 August 2017

32

1 reference

12 August 2017

6

1 reference

12 August 2017

483-489

1 reference

Lifestyle intervention and coronary heart disease risk factor changes over 18 months in postmenopausal women: the Women On the Move through Activity and Nutrition (WOMAN study) clinical trial.

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Aspirin, statins, or both drugs for the primary prevention of coronary heart disease events in men: a cost-utility analysis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Cardioprotective effects and gastrointestinal risks of aspirin: maintaining the delicate balance

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Tracking women's awareness of heart disease: an American Heart Association national study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

National use of postmenopausal hormone therapy: annual trends and response to recent evidence

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

The emergence of the metabolic syndrome with menopause

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Postmenopausal hormone therapy and the risk of cardiovascular disease: the epidemiologic evidence

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Postmenopausal women and cardiovascular risk: impact of hormone replacement therapy.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Women's Healthy Lifestyle Project: A randomized clinical trial: results at 54 months

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Prevention of heart disease in women: recommendations for management of risk factors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Intensive lifestyle changes for reversal of coronary heart disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Development of questionnaire to examine relationship of physical activity and diabetes in Pima Indians

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Energy intake and physical activity in Pima Indians: comparison with energy expenditure measured by doubly-labeled water.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Promotion and prescribing of hormone therapy after report of harm by the Women's Health Initiative

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Lifestyle intervention can prevent weight gain during menopause: results from a 5-year randomized clinical trial

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmö feasibility study

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

The Diet Habit Survey: a new method of dietary assessment that relates to plasma cholesterol changes

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2040271

Menopause and risk factors for coronary heart disease

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17533063

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17533063

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A collection of Physical Activity Questionnaires for health-related research

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17533063

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.AMEPRE.2007.02.019

1 reference

12 August 2017

1 reference

12 August 2017

1 reference